Clinical Trials Browser

Phase 1 × IPH-2101 × Other hematologic neoplasm × Clear all

NCT01256073 2014-02-28

A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute